The leading integrated facility management services provider informed the stock exchanges in a filing that the Ministry of ...

Krystal, the original home of the slider in the South, is serving up more ways to satisfy cravings with the launch of all-new ...

Jefferies has initiated Krystal Biotech at buy citing growth in sales of Vyjuvek (beremagene geperpavec), a gene therapy for ...

KRYS stock surges 15% in a month on strong uptake of Vyjuvek and encouraging pipeline progress. We are optimistic about the stock as we believe there is room for further growth.

The contract details were informed in a stock exchange filing by KISL, the facility management services provider.

PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA’s) ...

Krystal Biotech said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Vyjuvek topical gene therapy for certain patients with the rare ...

Krystal Integrated Services secures sanitation contract with Ministry of Health, emphasizing importance of cleanliness in ...